Company & Sponsor Intelligence

Sahlgrenska University Hospital

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials5

Recruiting1

Completed4

Countries2

Therapeutic footprint

alzheimersepilepsypain_neuropathyparkinsonssubstance_use

Indexed studies

NCT04710355Objective Data on Daily Activity in Patients Treated with SCS: the Intellis Study
pain_neuropathy · BelgiumCOMPLETED

NCT02409082Alzheimers Disease and Neuromarkers in Patients With Acute Hip Fractures
alzheimers · SwedenCOMPLETED

NCT00846859Does Varenicline Influence Alcohol Consumption in Alcohol Dependent Individuals?
substance_use · SwedenPHASE2

NCT07116330Late-Onset Seizures: Trial of Vascular Risk Investigation and Treatment
epilepsy · SwedenRECRUITING

NCT03152721The Effect of Parkinson Kinetigraph Recordings on the Management and Outcome in Parkinson's Disease
parkinsons · SwedenNA

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →